Complement C4 Is Protective for Lupus Disease Independent of C3
Open Access
- 1 February 2002
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 168 (3) , 1036-1041
- https://doi.org/10.4049/jimmunol.168.3.1036
Abstract
The role of complement C3 in mediating systemic lupus erythematosus (SLE) was examined using a double-knockout C3nullC4null Fas (CD95)-deficient mouse model. Results from this study reveal significant lymphadenopathy, splenomegaly, elevated titers of anti-nuclear Abs and anti-dsDNA Abs, an increased number of anti-dsDNA-producing cells in ELISPOT assay, as well as severe glomerulonephritis in the double-deficient mice. Based on these clinical, serological, and histological parameters, we find that autoimmune disease in the double-knockout group is similar in severity to that in C4nulllpr mice, but not to that in C3nulllpr mice. The development of severe SLE in the absence of both classical and alternative complement pathways suggests that it is the absence of C4, and not the presence of C3, that is critical in SLE pathogenesis. Thus, complement C4 provides an important protective role against the development of SLE.Keywords
This publication has 38 references indexed in Scilit:
- Complement C4 Inhibits Systemic Autoimmunity through a Mechanism Independent of Complement Receptors Cr1 and Cr2The Journal of Experimental Medicine, 2000
- Regulation of B Lymphocyte Responses to Foreign and Self-Antigens by the CD19/CD21 ComplexAnnual Review of Immunology, 2000
- Complement and immune complexesResearch in Immunology, 1996
- Complement deficiency and diseaseImmunology Today, 1991
- Expression of anti-DNA immunoglobulin transgenes in non-autoimmune miceNature, 1991
- Spontaneous antibody-secreting cells against DNA and common environmental antigens in systemic lupus erythematosusJournal of Autoimmunity, 1990
- Anti-DNA antibody production by CD5+ and CD5- B cells of patients with systemic lupus erythematosus.Journal of Clinical Investigation, 1990
- Systemic autoimmune disease arises from polyclonal B cell activation.The Journal of Experimental Medicine, 1987
- The Role of Complement and Its Receptor in the Elimination of Immune ComplexesNew England Journal of Medicine, 1986
- PERIODATE-LYSINE-PARAFORMALDEHYDE FIXATIVE A NEW FIXATIVE FOR IMMUNOELECTRON MICROSCOPYJournal of Histochemistry & Cytochemistry, 1974